Risk of medication-related osteonecrosis of the jaws (MRONJ) in osteoporotic patients treated with antiresorptive drug therapy and dental implants
Crossref DOI link: https://doi.org/10.1038/s41432-026-01225-z
Published Online: 2026-05-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pruthi, Gunjan
Text and Data Mining valid from 2026-05-21
Version of Record valid from 2026-05-21
Article History
Received: 20 February 2026
Accepted: 22 April 2026
First Online: 21 May 2026
Competing interests
: The author declares no competing interests.